Gelonghui, April 24 | Sinopharm Hyundai (600420.SH) said on the investor interactive platform that the company currently has glucose-lowering drugs such as engliflozin tablets, as well as the active ingredients acarbose and voglibose. None of the above drugs currently have any weight-loss-related indications.
国药现代(600420.SH)：公司目前降糖类药物有恩格列净片
Sinopharm Hyundai (600420.SH): The company's current hypoglycemic drugs include engagliflozin tablets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.